Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S J Edwards

Showing results (111-120 of 120) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 120 results.
The Journal of Allergy and Clinical Immunology|May 26, 2018
Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunityEmily S J Edwards, Julia Bier, Theresa S Cole, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 17, 2011
Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer stainingMathew Clement, Kristin Ladell, Julia Ekeruche-Makinde, et al.
The Journal of Allergy and Clinical Immunology|April 13, 2026
Three-dose COVID-19 vaccination elicits immune memory in patients with inborn errors of immunity even in the absence of neutralizing antibodiesEmily S J Edwards, Raffi Gugasyan, Nirupama Varese, et al.
The Journal of Biological Chemistry|September 7, 2012
T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targetingJulia Ekeruche-Makinde, Mathew Clement, David K Cole, et al.
The Journal of Allergy and Clinical Immunology|June 5, 2023
TCF3 haploinsufficiency defined by immune, clinical, gene-dosage, and murine studiesBrigette Boast, Shubham Goel, Luis I González-Granado, et al.
The Journal of Allergy and Clinical Immunology|February 10, 2019
Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4<sup>+</sup> T cellsJulia Bier, Geetha Rao, Kathryn Payne, et al.
Cell Reports|October 9, 2024
Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activityEthan P Oxley, Nadia J Kershaw, Cynthia Louis, et al.
The Journal of Experimental Medicine|December 25, 2016
Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiencyHassan Abolhassani, Emily S J Edwards, Aydan Ikinciogullari, et al.
Blood|January 24, 2025
One hundred thirty-four germ line PU.1 variants and the agammaglobulinemic patients carrying themAinsley V C Knox, Lauren Y Cominsky, Di Sun, et al.
Blood|July 1, 2020
Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiencySujal Ghosh, Sevgi Köstel Bal, Emily S J Edwards, et al.
Pageof 12

Showing results (111-120 of 120) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 120 results.
The Journal of Allergy and Clinical Immunology|May 26, 2018
Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunityEmily S J Edwards, Julia Bier, Theresa S Cole, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 17, 2011
Anti-CD8 antibodies can trigger CD8+ T cell effector function in the absence of TCR engagement and improve peptide-MHCI tetramer stainingMathew Clement, Kristin Ladell, Julia Ekeruche-Makinde, et al.
The Journal of Allergy and Clinical Immunology|April 13, 2026
Three-dose COVID-19 vaccination elicits immune memory in patients with inborn errors of immunity even in the absence of neutralizing antibodiesEmily S J Edwards, Raffi Gugasyan, Nirupama Varese, et al.
The Journal of Biological Chemistry|September 7, 2012
T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targetingJulia Ekeruche-Makinde, Mathew Clement, David K Cole, et al.
The Journal of Allergy and Clinical Immunology|June 5, 2023
TCF3 haploinsufficiency defined by immune, clinical, gene-dosage, and murine studiesBrigette Boast, Shubham Goel, Luis I González-Granado, et al.
The Journal of Allergy and Clinical Immunology|February 10, 2019
Activating mutations in PIK3CD disrupt the differentiation and function of human and murine CD4<sup>+</sup> T cellsJulia Bier, Geetha Rao, Kathryn Payne, et al.
Cell Reports|October 9, 2024
Context-restricted PD-(L)1 checkpoint agonism by CTLA4-Ig therapies inhibits T cell activityEthan P Oxley, Nadia J Kershaw, Cynthia Louis, et al.
The Journal of Experimental Medicine|December 25, 2016
Combined immunodeficiency and Epstein-Barr virus-induced B cell malignancy in humans with inherited CD70 deficiencyHassan Abolhassani, Emily S J Edwards, Aydan Ikinciogullari, et al.
Blood|January 24, 2025
One hundred thirty-four germ line PU.1 variants and the agammaglobulinemic patients carrying themAinsley V C Knox, Lauren Y Cominsky, Di Sun, et al.
Blood|July 1, 2020
Extended clinical and immunological phenotype and transplant outcome in CD27 and CD70 deficiencySujal Ghosh, Sevgi Köstel Bal, Emily S J Edwards, et al.
Pageof 12